{
  "meta": {
    "timestamp": "2025-01-06T09:03:01.911595",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Fortrea Holdings Inc.",
      "symbol": "FTRE",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Regulatory and compliance risks due to evolving global requirements and potential securities fraud investigation",
            "Data privacy and security risks from handling sensitive patient data",
            "Client concentration risk with significant revenue dependency on a few large clients",
            "Competitive pressures in the CRO industry leading to pricing and margin challenges"
          ],
          "controversies": [
            "Investigation by Pomerantz LLP for potential securities fraud, breaches of fiduciary duty, and corporate misconduct",
            "Bearish trading activity and high Put/Call Ratio indicating investor skepticism"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Ethical challenges related to patient consent, trial transparency, and global health equity",
            "Efforts to improve diversity in clinical trials must be effectively implemented to avoid criticism"
          ],
          "governance_issues": [
            "Potential legal liabilities and reputational damage from ongoing investigations",
            "Stock holdings trimmed by Principal Financial Group Inc., reflecting valuation or performance concerns"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Fortrea Holdings Inc Securities and Exchange Commission",
              "snippet": "stock of FORTREA HOLDINGS INC is more than five percent of the total outstanding common stock. Item 7. Identification and Classification of the Subsidiary Which ... United States or non-United States governmental or regulatory authority, including, without limitation, Schedules 13D and 13G and Forms 3, 4, 5, 13F",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:30.834830+00:00",
              "published_date": null,
              "source_hash": "7709de58b86bdd76dd29429394f2af2d"
            },
            {
              "url": "",
              "title": "FTRE SEC Filings - Fortrea Holdings Inc.- Annual Report, Proxy ... - Fintel",
              "snippet": "FTRE / Fortrea Holdings Inc. - SEC Filings, Annual Report, Proxy Statement Fortrea Holdings Inc. NasdaqGS ... risk, controls and compliance in accor ... Issues Full-Year 2024 Guidance For the three months ended December 31, 2023 and full year 2023: \u2022Revenues of $775.4 million for fourth quarter, $3,109.0 million for the full year \u2022GAAP net ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:30.834941+00:00",
              "published_date": null,
              "source_hash": "d2deb46ed091e32c977ca7c5f25bf308"
            },
            {
              "url": "",
              "title": "Fitch Assigns Final Ratings to Fortrea Holdings, Inc.; Outlook Stable",
              "snippet": "Fortrea Holdings, Inc. is a CRO that provides clinical development and commercialization services and software applications supporting clinical trials to the biopharmaceutical and medical device industries. ... This means ESG issues are credit-neutral or have only a minimal credit impact on the entity, either due to their nature or the way in ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:30.834963+00:00",
              "published_date": null,
              "source_hash": "e1a4f78e3e261c89af7f1693cce81d1d"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (FTRE) 10K Annual Reports & 10Q SEC Filings",
              "snippet": "Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance. For the three months ended December 31, 2023 and full year 2023: ... The following information was filed by Fortrea Holdings Inc. (FTRE) on Monday, March 11, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:30.834977+00:00",
              "published_date": null,
              "source_hash": "53488c7296a16567fc5b45eb71fe019f"
            },
            {
              "url": "",
              "title": "SEC Filing - Fortrea",
              "snippet": "This Current Report on Form 8-K/A (this \" Amendment \") is being furnished by Fortrea Holdings Inc. (the \" Company \") to correct the calculation in the reconciliation of the Trailing Twelve Months Ended June 30, 2023 Adjusted EBITDA figure (the \" Trailing 12 Adjusted EBITDA \") previously provided by the Company in its second quarter ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:30.834990+00:00",
              "published_date": null,
              "source_hash": "a5a5250e239d20e2975903a3f774ddc1"
            },
            {
              "url": "",
              "title": "SEC Filing - Fortrea",
              "snippet": "Fortrea Holdings Inc. (the \"Registrant\") will provide all participants in the Fortrea Holdings Inc. 2023 Omnibus Incentive Plan and the Fortrea Holdings Inc. 2023 Employee Stock Purchase Plan (as each may be amended from time to time, the \"Plans\") with the applicable document(s) containing the information required by Part I of Form S-8, as specified in Rule 428(b)(1) promulgated by the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:30.835000+00:00",
              "published_date": null,
              "source_hash": "9a80bc36771997d3632dd6ae33d25973"
            },
            {
              "url": "",
              "title": "SEC Filing | Fortrea",
              "snippet": "Fortrea Holdings Inc. (the \"Company\") hereby provides responses to the comments received from the staff (the \"Staff\") of the United States Securities and Exchange Commission (the \"Commission\") set forth in the comment letter dated April 19, 2023 (the \"Comment Letter\") with respect to the above-referenced Amendment No. 1 to Draft Registration Statement on Form 10 (\"Amendment ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:30.835013+00:00",
              "published_date": null,
              "source_hash": "dbfd1d3538249c55812a42ef74a3bf63"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. - Fitch Ratings",
              "snippet": "Fortrea Holdings Inc. Fri 30 Aug, 2024 - 11:16 AM ET The one-notch downgrade of Fortrea Holdings, Inc.'s Long-Term Issuer Default Rating (IDR) by Fitch Ratings in June 2024 reflects Fortrea's weak operating performance following its spin-off in July 2023, including weakening FCF generation and slower progression in margin improvements than ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:30.835023+00:00",
              "published_date": null,
              "source_hash": "8211560dfcbe86f198f227d6321f6524"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...",
              "snippet": "NEW YORK, Jan. 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (\"Fortrea\" or the \"Company\") (NASDAQ: FTRE).Such investors are advised ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160369+00:00",
              "published_date": null,
              "source_hash": "a9dd1de2758089faf44473b09d06be52"
            },
            {
              "url": "",
              "title": "Investigating Fortrea Holdings: What Investors Need to Know",
              "snippet": "Fortrea Holdings Inc. is a well-known player in the contract research organization sector. The company has focused on providing critical research and development services to the biotechnology industry. It positions itself as an important partner for biotech firms aiming to navigate the complex landscape of research and regulatory requirements.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:30.835045+00:00",
              "published_date": null,
              "source_hash": "c0787cbf30591ff7ae15c79c6df055e5"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc put volume heavy and directionally bearish",
              "snippet": "Bearish flow noted in Fortrea ( FTRE) Holdings Inc with 1,065 puts trading, or 1.0x expected. Most active are Jan-25 17.5 puts and Jan-25 20 puts, with total volume in those strikes near 1,000 contracts. The Put/Call Ratio is 44.38, while ATM IV is up nearly 2 points on the day. Earnings are expected on March 10th.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:33.319536+00:00",
              "published_date": "2025-01-02T18:34:00+00:00",
              "source_hash": "d852d942a45dc7f1b36eeefb9f8349d7"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE",
              "snippet": "NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (\"Fortrea\" or the \"Company\") (NASDAQ:FTRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:33.319629+00:00",
              "published_date": "2025-01-03T17:08:00+00:00",
              "source_hash": "3b1e507ac5a3adc0f6e8d76681c82965"
            },
            {
              "url": "",
              "title": "Here's Why Fortrea Holdings Inc. (FTRE) Is Among The Stocks Targeted By Activist Hedge Funds",
              "snippet": "We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, we are going to take a look at where Fortrea Holdings Inc. (NASDAQ:FTRE) stands against the other stocks targeted by activist hedge funds.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:33.319659+00:00",
              "published_date": "2025-01-03T11:29:54+00:00",
              "source_hash": "13395134c4fc0f57d60ece2e981d08dd"
            },
            {
              "url": "",
              "title": "Analysts Set Fortrea Holdings Inc. (NASDAQ:FTRE) Price Target at $23.30",
              "snippet": "Shares of Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) have been assigned a consensus recommendation of \"Reduce\" from the twelve brokerages that are covering the company, MarketBeat reports.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:43.536162+00:00",
              "published_date": "2024-12-23T05:29:00+00:00",
              "source_hash": "ab104b2fb0149eb2eeb9bbdebe926d8d"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (NASDAQ:FTRE) Stock Holdings Trimmed by Principal Financial Group Inc.",
              "snippet": "View Our Latest Stock Analysis on FTRE Fortrea Trading Up 1.2 % Fortrea stock opened at $18.65 on Wednesday. Fortrea Holdings Inc. has a 52 week low of $16.53 and a 52 week high of $41.02. The ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:33.319709+00:00",
              "published_date": "2025-01-01T00:00:00+00:00",
              "source_hash": "8fde310156267b74b194993e128b3e03"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc, FTRE:NSQ profile - FT.com - Financial Times",
              "snippet": "Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160183+00:00",
              "published_date": null,
              "source_hash": "9d6e8c63f49fa462ccf59b12da3a2eea"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc (FTRE) Reports Mixed 2023 Results and Sets 2024 ...",
              "snippet": "On March 11, 2024, Fortrea Holdings Inc (NASDAQ:FTRE) released its 8-K filing, detailing its financial performance for the fourth quarter and full year of 2023. The company, a leading global ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160296+00:00",
              "published_date": null,
              "source_hash": "c82230a6ef3cca5c6e095c82fe25dbd2"
            },
            {
              "url": "",
              "title": "Here's Why Fortrea Holdings Inc. (FTRE) Is Among The Stocks Targeted By ...",
              "snippet": "We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, we are going to take a look at where Fortrea Holdings Inc. (NASDAQ:FTRE) stands against the other ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160311+00:00",
              "published_date": null,
              "source_hash": "e6bc514a53e06a0ef38a7bb6832a3807"
            },
            {
              "url": "",
              "title": "News Releases - Fortrea",
              "snippet": "For the three months ended September 30, 2024, from continuing operations: Revenues of $674.9 million GAAP net loss of $(18.5) million Adjusted EBITDA of $64.2 million GAAP and adjusted net income (loss) per diluted share of $(0.21) and $0.23, respectively Book-to-bill ratio of 1.23x, resulting in",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160324+00:00",
              "published_date": null,
              "source_hash": "3bc58475ae14a8fb7b0399fcc1de1bcd"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ... - Morningstar",
              "snippet": "NEW YORK, Dec. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (\"Fortrea\" or the \"Company\") (NASDAQ: FTRE). Such investors are advised ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160336+00:00",
              "published_date": null,
              "source_hash": "9e2e8ac1ebbf920aee5c8a514452c1b2"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (FTRE) - Stock Analysis",
              "snippet": "Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings Inc. (FTRE) Stockholders to Inquire about Securities Investigation. NEW YORK CITY, NY / ACCESSWIRE / October 9, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortrea Holdings Inc. (\"Fortrea\" or \"the Company\") (N...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160347+00:00",
              "published_date": null,
              "source_hash": "68b5c68cc19b8a6fc76c4449aeb1ad21"
            },
            {
              "url": "",
              "title": "FTRE | Fortrea Holdings Inc. Profile | MarketWatch",
              "snippet": "Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160358+00:00",
              "published_date": null,
              "source_hash": "d114b21d514a18f101708920fd675cf9"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. Company Profile & Data: stocks, market cap ...",
              "snippet": "It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160379+00:00",
              "published_date": null,
              "source_hash": "fb5ceaa60af61901a2fa25c6974dd9a0"
            },
            {
              "url": "",
              "title": "FTRE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an ...",
              "snippet": "On September 25, 2024, Jefferies downgraded Fortrea, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:35.160392+00:00",
              "published_date": null,
              "source_hash": "9e716d4240e63dc82d39ede5bce1a76a"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (NASDAQ:FTRE) Stock Holdings Trimmed by Principal Financial Group Inc.",
              "snippet": "According to data ... Inc. will post 0.57 EPS for the current year. Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:37.597460+00:00",
              "published_date": "2025-01-01T00:00:00+00:00",
              "source_hash": "615e34f46c21db3837b60385685cd9e2"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE",
              "snippet": "NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (\"Fortrea\" or the \"Company ... rights of the victims of securities fraud, breaches of fiduciary duty, and corporate ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:37.597506+00:00",
              "published_date": "2025-01-03T17:08:00+00:00",
              "source_hash": "e1f8c8a26ff75ae7635f9f1ad1aa49ff"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (NASDAQ:FTRE) Q3 2024 Earnings Call Transcript",
              "snippet": "Fortrea Holdings Inc. (NASDAQ:FTRE) Q3 2024 Earnings Call ... Fortrea has just been named a finalist in Fierce Healthcare's Excellence in Data-Driven DEI Award for our DEI Dashboard.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:37.597518+00:00",
              "published_date": "2024-11-09T20:28:00+00:00",
              "source_hash": "3e1999c1ab4d0465f4e7d7bafac122a0"
            },
            {
              "url": "",
              "title": "FTRE Fortrea Holdings Inc.",
              "snippet": "View Fortrea Holdings Inc. (FTRE) current and estimated P/E ratio data provided by Seeking Alpha.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. patient data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:37.597526+00:00",
              "published_date": "2024-12-18T00:00:00+00:00",
              "source_hash": "c1edc804c53969f7d4503c56389d355a"
            },
            {
              "url": "",
              "title": "Diversity & Inclusion in Clinical Trials - Fortrea",
              "snippet": "Leverage in-study diversity insights with the Fortrea Diversity and Inclusion Study Insights Dashboard. Leading the way on Diversity Action Plans On June 26, 2024, the U.S. FDA's draft guidance on improving diversity was published: Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies .",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983597+00:00",
              "published_date": null,
              "source_hash": "0b04149a0f127392b98edd7797f898af"
            },
            {
              "url": "",
              "title": "Diversity & Inclusion - Fortrea",
              "snippet": "Previously, Tom served as CEO and a member of the Board of Directors of Quintiles Transnational Holdings, Inc. (NYSE: Q), a leading fully integrated biopharmaceutical services company, from April 2012 until its merger with IMS Health in 2016 to create IQVIA (NYSE: IQV). ... Fortrea's commitment to diversity and inclusion is the foundation of ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983720+00:00",
              "published_date": null,
              "source_hash": "4fe3a007ecde205de0afcd9a85302dfc"
            },
            {
              "url": "",
              "title": "Fortrea Introduces Comprehensive Solution to Improve Diversity and ...",
              "snippet": "Fortrea Holdings Inc. Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983740+00:00",
              "published_date": null,
              "source_hash": "41b541f680c268e2e296a99f010d6058"
            },
            {
              "url": "",
              "title": "Fortrea Introduces Comprehensive Solution to Improve - GlobeNewswire",
              "snippet": "Fortrea's D&I solution is designed to expand patient access to participate in clinical trials and address the U.S. Food and Drug Administration (FDA) requirements, under The Food and Drug ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983755+00:00",
              "published_date": null,
              "source_hash": "fe639c502ef0888304ad77fa4840e0f6"
            },
            {
              "url": "",
              "title": "Fortrea Holdings introduces solution to improve diversity in clinical ...",
              "snippet": "Fortrea announced its comprehensive and integrated solution to improve the diversity and inclusion of participants in clinical trials. Fortrea's D&I solution is designed to expand patient access to participate in clinical trials and address the U.S. Food and Drug Administration requirements, under The Food and Drug Omnibus Reform Act, to increase enrollment of underrepresented populations in ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983768+00:00",
              "published_date": null,
              "source_hash": "05b924b29ce8538f793a93972adee2d1"
            },
            {
              "url": "",
              "title": "Fortrea Announces AI-Driven Partnership with Medidata to Increase ...",
              "snippet": "Fortrea Holdings Inc. Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies. DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983780+00:00",
              "published_date": null,
              "source_hash": "daabf7bfb32fcf805426196bc3da08f1"
            },
            {
              "url": "",
              "title": "Culture | Fortrea",
              "snippet": "A culture of innovation. Fortrea is bringing a cultural shift to the clinical research industry. We're giving clinical trial sponsors flexible and agile solutions while helping investigator sites improve their productivity, reduce complexity and make it easier for them to conduct studies.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983794+00:00",
              "published_date": null,
              "source_hash": "a97dbf3623ee2039d5d1379dff36eac8"
            },
            {
              "url": "",
              "title": "Fortrea Introduces Comprehensive Solution to Improve Diversity and ...",
              "snippet": "Fortrea's D&I solution is designed to expand patient access to participate in clinical trials and address the U.S. Food and Drug Administration (FDA) requirements, under The Food and Drug ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983806+00:00",
              "published_date": null,
              "source_hash": "82c079153b6bf63e4f9b149e3427eaf7"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. Company Profile - Dun & Bradstreet",
              "snippet": "Find company research, competitor information, contact details & financial data for Fortrea Holdings Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet. Fortrea Holdings Inc. D&B Business Directory HOME / BUSINESS ... Valuable research and technology reports. Get a D&B Hoovers Free Trial.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983817+00:00",
              "published_date": null,
              "source_hash": "e7f1b3b1915084dfe89a6b561e4bd8c2"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc (FTRE) Q3 2024 Earnings Call Highlights ...",
              "snippet": "Fortrea Holdings Inc (NASDAQ:FTRE) has been recognized externally, being named a finalist in Fierce Healthcare's excellence and data-driven DEI award and the CRO of the Year category in the annual ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:40.983829+00:00",
              "published_date": null,
              "source_hash": "965f4eac7d210fcc459b1aea706ba3fc"
            },
            {
              "url": "",
              "title": "Here's Why Fortrea Holdings Inc. (FTRE) Is Among The Stocks Targeted By Activist Hedge Funds",
              "snippet": "According to Starboard, Fortrea Holdings Inc. (NASDAQ:FTRE) is ideally positioned as a sizable and diverse international contract research organization, or CRO, offering drug and other research ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:43.536020+00:00",
              "published_date": "2025-01-03T06:29:00+00:00",
              "source_hash": "9f22b2d7ca76f7652560148d370016ba"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE",
              "snippet": "NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (\"Fortrea\" or the \"Company ... the Company's business model as a contract research organization amid pressure on ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:43.536107+00:00",
              "published_date": "2025-01-03T17:08:00+00:00",
              "source_hash": "559ce86038b4dafef30b77d00a6673a5"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (NASDAQ:FTRE) Stock Holdings Trimmed by Principal Financial Group Inc.",
              "snippet": "Research analysts forecast that Fortrea Holdings Inc. will post 0.57 EPS for the ... The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:43.536136+00:00",
              "published_date": "2025-01-01T00:00:00+00:00",
              "source_hash": "e70b04eb0d0415bf2d8e89009a8b7137"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (NASDAQ:FTRE) Q3 2024 Earnings Call Transcript",
              "snippet": "Fortrea Holdings Inc. (NASDAQ:FTRE ... often complex goals with clinical research. In Q3, we published our inaugural Corporate Social Responsibility Report, underscoring our commitment to safety ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. diversity in clinical trials controversies",
              "retrieved_at": "2025-01-06T16:02:43.536186+00:00",
              "published_date": "2024-11-09T20:28:00+00:00",
              "source_hash": "0230a3f6e94075c826dafc38db38f8e7"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Fortrea Holdings Inc. regulatory compliance issues",
              "rationale": "Investigate potential legal and regulatory challenges impacting clinical trials",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Fortrea Holdings Inc. patient data privacy breaches",
              "rationale": "Assess risks related to handling sensitive patient data and cybersecurity measures",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Fortrea Holdings Inc. diversity in clinical trials controversies",
              "rationale": "Examine concerns or criticisms regarding diversity and inclusion in trial participation",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T09:03:01.911600",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}